Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

Metcalfe, K, Gershman, S, Lynch, H T, Ghadirian, P, Tung, N, Kim-Sing, C, Olopade, O I, Domchek, S +6 more·2011·British Journal of Cancer
DOI 10.1038/bjc.2011.120

Cited by (232)

Items 201–232 of 232

  1. CÁNCER DE MAMA BILATERAL: EXPERIENCIA EN EL SERVICIO ONCOLÓGICO HOSPITALARIO–IVSS
    Josepmilly Peña C, José Muñoz, Leider Campos, Yanira Vuolo, Álvaro Gómez, Juan Carlos Rodrı́guez, Yasmín Velásquez, Tatiana Fandiño, Carlos Pacheco S · 2016 · Revista Venezolana de Oncología
  2. Folate and Folic Acid Supplement Use and Breast Cancer Risk in BRCA1/2 Mutation Carriers
    Shana Jean Kim · 2016 · TSpace (University of Toronto)
  3. Surgery and radiotherapy: patient selection and clinical outcomes
    Travis L Holloway, Ismail Jatoi · 2013
  4. Sport und Ernährung in der Prävention des erblichen Brustkrebses
    Sabine Grill, Anne S. Quante, Marion B. Kiechle · 2019 · Der Gynäkologe
  5. Hereditary Breast Cancer: Prophylactic Mastectomy, Breast Conservation, and Rates of Cancer
    Siun M. Walsh, Mark E. Robson, Virgilio Sacchini · 2019 · Springer eBooks
  6. Mastectomia contralateral redutora de risco e sobrevida em mulheres com câncer de mama e mutação nos genes BRCA1 e BRCA2. Revisão sistemática e meta-análise
    Natália Polidorio Machado · 2019
  7. Locoregional Management of Hereditary Breast Cancer
    Maria João Cardoso · 2020 · Springer eBooks
  8. Bi-rads final assessment categories in breast cancer patients
    T.W.V. Daniels · 2019
  9. Primary multiple BRCA associated breast cancer and ovarian cancer (clinical case)
    И. Б. Кононенко, Снеговой Антон Владимирович, Yana A. Bozhchenko, Dmitry Kravchenko, Vladimir Yu. Selchuk, O. V. Palchinskaia · 2020 · Meditsinskiy sovet = Medical Council
  10. Late Effects in Young Breast Cancer Survivors
    Michael Patrick Lux, Diana Lüftner, Dominik T. Schneider · 2020 · Springer eBooks
  11. A reproductive dilemma?
    Gietel-Habets Joyce Josefine Giacomina · 2020
  12. Bilateral prophylactic mastectomy as an option for prevention of contralateral breast cancer
    D.V. Pominchuk, T.S. Shevchuk · 2020 · Reproductive Endocrinology
  13. P307 冬季南岸低気圧の発達初期段階における雲システムの微物理的・電気的構造(ポスターセッション)
    蓉子 吉住, 哲也 川野, 隆一 川村, 賢士 鈴木, 靖博 齊藤 · 2014 · 大会講演予講集
  14. WOMEN WITH BREAST CANCER ATTENDED IN PUBLIC HOSPITAL FROM MACAPÁ, AMAPÁ
    Emílio Daniel Pacheco de Sousa, Givago da Silva Souza, Nely Dayse Santos da Mata, Marlucilena Pinheiro da Silva, José Mauro Secco · 2021 · International Journal for Innovation Education and Research
  15. Somatic copy number alterations modulate tumor suppressor and oncogene expression to drive early onset of breast cancer
    Pamela Derliche Tonouo, Esther Hortense Murielle Dina Bell, Arnol Auvaker Zébazé Tiofack, Eliane Ndounga, Sidonie Noa Ananga, Etienne Atenguena, Gustave Simo, Abdel Jélil Njouendou, Smiths Lueong · 2022 · Research Square
  16. Second Malignant Neoplasms
    Debra L. Friedman · 2020 · Elsevier eBooks
  17. Genetic Syndromes and RT for Breast Cancer
    Rinat Bernstein‐Molho, Bella Kaufman, Lynda Wyld · 2022 · Springer eBooks
  18. Bilateral Synchronous and Metachronous Breast Cancer: Features of Topography, Etiology, Pathogenesis, Risk Factors, Diagnosis and Prognosis
    Liliya I. Volos, З. З. Масна, M.A.L. Vasyliv · 2022 · Ukraïnsʹkij žurnal medicini bìologìï ta sportu
  19. Hereditary Breast Cancer Non-CDH1 Associated
    Rosa Di Micco, Emanuela Esposito, Giuseppe Accardo, Andrea Sibilio, A. Kouloura, Mara Jordana Magalhães Costa, Oreste ­Gentilini · 2023 · Springer eBooks
  20. Genetics and Prevention
    Jodi Leigh Brehm, Deborah Wham · 2024 · Elsevier eBooks
  21. Synchronous Primary Gallbladder and Colon Adenocarcinoma: A Case Report and Systematic Literature Review
    Paraskevi Dedopoulou, Nikiforos Rodis, Charalampos Lampropoulos, Konstantina Soultana Kitsou, Nikolaos Mpogiatzopoulos, Ioannis Kehagias · 2024 · Cureus
  22. Secondary Risk-Reducing Strategies for Contralateral Breast Cancer in BRCA1/2 Variant Carriers: A Systematic Review and Meta-analysis
    Jing Yu, Shan Jiang, Taoran Liu, Yangyang Gao, Xinyang Ma, Ginenus Fekadu, Yunqiu Xia, Bonny Parkinson, Wai‐Kit Ming, Yuanyuan Gu · 2024 · Advances in Therapy
  23. Successful BRCA2 Mutation Detection via Tissue-Based Gene Panel Testing in Post-bone Marrow Transplant Breast Cancer: Implications for Precision Medicine
    Chisato Takeuchi, Seiichi Imanishi, Namiko Tanaka, Nobuyoshi Kittaka · 2025 · Cureus
  24. Comment: Survival after risk-reducing mastectomy in young BRCA1 carriers with breast cancer
    Vasily Giannakeas, Steven Alexander Narod · 2025 · BJC Reports
  25. Breast Cancer in Women with Moderate and High Penetrance Germline Pathogenic Variants in Breast Cancer Susceptibility Genes
    Stephanie M. Wong, Kelly A. Metcalfe · 2025 · Current Breast Cancer Reports
  26. The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer
    Pēteris Loža, Arvīds Irmejs, Zanda Daneberga, Jeļena Maksimenko, Genādijs Trofimovičs, Signe Subatniece, Jacek Gronwald, Jan Lubiński, Jānis Gardovskis · 2025 · BMC Cancer
  27. Risk-reducing mastectomy and salpingo-oophorectomy in women with hereditary breast and ovarian cancer: a single-institute experience following coverage by Japanese national medical insurance
    Akimitsu Yamada, Masanori Oshi, Takumi Isa, Tomohiro Koyasu, Mii Takatsuka, Hiroko Kuriki, Maya Isoda, Kei Kawashima, Mahato Sasamoto, Yuka Matsubara et al. · 2025 · Japanese Journal of Clinical Oncology
  28. FIGURE 2 in Description of a new species of Caenotus Cole (Diptera: Scenopinidae) from Baja California Sur, Mexico, with a review of the genus
    Mark A. Metz · 2003 · INFM-OAR (INFN Catania)
  29. Additional file 1 of Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis
    Jia, Ziqi, Li, Jiaxin, Yuelun Zhang, Wang, Xin, Xing, Jiahua, Zeyu Xing, Xin Huang, Gang Liu, Menglu Zhang, Feng, Kexin et al. · 2021 · Figshare
  30. Additional file 1 of Increased risk of contralateral breast cancer for BRCA1/2 wild-type, high-risk Korean breast cancer patients: a retrospective cohort study
    Eunhye K. Kang, Jung, Ji-Jung, Lim, Changjin, Kim, Hong-Kyu, Lee, Han-Byoel, Han, Wonshik, Moon, Hyeong-Gon · 2024 · Figshare
  31. Prédispositions génétiques au cancer du sein et de l'ovaire dans la population suisse entre 1996 et 2009 : bilan de l'activité oncogénétique et du dépistage de mutations constitutionnelles dans les gènes BRCA1/BRCA2
    Aurélie Ayme · 2013
  32. BRCA1/BRCA2 MUTATIONS IN BREAST CANCER: CLINICAL SIGNIFICANCE, PROGNOSTAIC VALUE, AND THERAPEUTIC IMPLICATIONS
    Anita Strzykała, Igor Szlegiel, Oktawia Gwiaździńska, Jakub Lewandowski, Denis Myszak · 2026 · International Journal of Innovative Technologies in Social Science